Novel formulation of intranasal oxytocin contains magnesium (Mg2+), shown to potentiate the analgesic effects of oxytocin on the oxytocin receptor in animal models TNX-1900 blocks release of CGRP, a ...
-- Company Expects to Announce Topline Data from Primary Immunization Series by 2025, Followed by Topline Data from Booster Dose Approximately Nine Months Later -- SAN CARLOS, Calif., July 11, 2023 ...
What Is Anaphylaxis?- Anaphylaxis, also called anaphylactic shock, is a sudden, severe allergic reaction that needs immediate medical attention.- The primary treatment for anaphylaxis is epinephrine ...
-- Company Expects to Announce VAX-31 Infant Study Topline Safety, Tolerability and Immunogenicity Data from Primary Immunization Series in Mid-2026, Followed by Topline Data from the Booster Dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results